In Sept. 2005, we moved to new manufacturing site of Yongfeng Industry Park.
On Nov. 18, AT&M Biomaterials Co., Ltd launched with registration capital 30million RMB.
On Oct. 23, 2003, Coronary stent got the marketing approval.
On Jan. 17,2003, Vene Cava stainless steel stent, Nitinol series stent and delivery systems (Esophageal stent, Bile duct stent and Urethral stent)received marketing approval of SFDA.
Our mother company, AT&M went public on May 29, 2000 at Shenzhen stocks market.
Sitai New Technology development Co., Ltd merged into Advanced Technology & Materials Co., Ltd(AT&M).
We began to research stent products since 1991 cooperating with nationwide famous cardiovascular hospital-Fuwai cardiovascular hospital with support of NSFC.
On Nov. 16, Sitai New Technology development Co., Ltd was founded.
In 1987, the amalgam alloy products launched.
In 1984, Central Iron & Steel Research Institute(CISRI) began to research dental Amalgam cooperating with Peking University School of Stomatology.